Advanced company searchLink opens in new window

ROSEMONT PHARMACEUTICALS LIMITED

Company number 00924648

Charge code 0092 4648 0006

Created
25 March 2021
Delivered
31 March 2021
Status
Outstanding
Transaction Filed
Registration of a charge (MR01)

Persons entitled

  • Glas Trust Corporation Limited

Brief description

Intellectual property – tradmarks. Chargor: rosemont pharmaceuticals limited. Trademark: lexpec. Trademark number: UK00000934157. Classes: 5. renewal date: 20 november 2023. chargor: rosemont pharmaceuticals limited. Trademark: soltamox. Trademark number: EU002633329. Classes: 5. renewal date: 19 march 2022. please see instrument for further details.. Intellectual property – patents. Chargor: rosemont pharmaceuticals limited. Patent: methotrexate composition. Filing number: EP2614814, us 9855215. renewal date: 22 march 2021, 02 july 2021. chargor: rosemont pharmaceuticals limited. Patent: oral topiramate suspension formulations with. Extended shelf life and enhanced bioavailability. Filing number: wo/2020/104837. Renewal date: n/A. Chargor: rosemont pharmaceuticals limited. Patent: sertraline composition. Filing number: GB2474209. Renewal date: 8 july 2021. please see instrument for further details.. Intellectual property - domain names:. Chargor: rosemont pharmaceuticals limited. Registrar: ascio technologies inc.. Domain name: rosemontpharma.com. Renewal date: 10 october 2020. please see instrument for further details.
Contains fixed charge.
Contains floating charge.
Floating charge covers all the property or undertaking of the company.
Contains negative pledge.